CANbridge Pharmaceuticals Corporate Presentation Aug 2023 Disclaimer THIS DOCUMENT OR THE INFORMATION CONTAINED HEREIN IS NOT INTENDED TO AND DOES NOT CONSTITUTE ANY OFFER OR INVITATION, SOLICITATION, COMMITMENT OR ADV ERTISEMENT OF ANY OFFER FOR SUBSCRIPTION, PURHCASE OR SALE OF ANY SECURITIES, NOR SHALL ANY PART OF THIS DOCUMENT FORM THE BASIS OF OR BE RELIED ON IN CONNECTION WITH ANY CONTRACT OR COMMITMENT WHATSOEVER. This document contains strictly conf idential and proprietary inf ormation in relation ...

2022 Interim Results Aug 2022 CANBRIDGE, 1228.HK www.canbridgepharma.com Disclaimer THIS DOCUMENT OR THE INFORMATION CONTAINED HEREIN IS NOT INTENDED TO AND DOES NOT CONSTITUTE ANY OFFER OR INVITATION, SOLICITATION, COMMITMENT OR ADVERTISEMENT OF ANY OFFER FOR SUBSCRIPTION, PURHCASE OR SALE OF ANY SECURITIES, NOR SHALL ANY PART OF THIS DOCUMENT FORM THE BASIS OF OR BE RELIED ON IN CONNECTION WITH ANY CONTRACT OR COMMITMENT WHATSOEVER. This document contains strictly confidential and proprietary information ...

CANbridge Pharmaceuticals FY2022 Annual Results Presentation March 2023 0 Disclaimer THIS DOCUMENT OR THE INFORMATION CONTAINED HEREIN IS NOT INTENDED TO AND DOES NOT CONSTITUTE ANY OFFER OR INVITATION, SOLICITATION, COMMITMENT OR ADVERTISEMENT OF ANY OFFER FOR SUBSCRIPTION, PURHCASE OR SALE OF ANY SECURITIES, NOR SHALL ANY PART OF THIS DOCUMENT FORM THE BASIS OF OR BE RELIED ON IN CONNECTION WITH ANY CONTRACT OR COMMITMENT WHATSOEVER. To be a Global Biopharmaceutical Company This document contains strictly ...

CANbridge Pharmaceuticals 2023 Interim Result Presentation Aug 2023 Disclaimer THIS DOCUMENT OR THE INFORMATION CONTAINED HEREIN IS NOT INTENDED TO AND DOES NOT CONSTITUTE ANY OFFER OR INVITATION, SOLICITATION, COMMITMENT OR ADV ERTISEMENT OF ANY OFFER FOR SUBSCRIPTION, PURHCASE OR SALE OF ANY SECURITIES, NOR SHALL ANY PART OF THIS DOCUMENT FORM THE BASIS OF OR BE RELIED ON IN CONNECTION WITH ANY CONTRACT OR COMMITMENT WHATSOEVER. This document contains strictly conf idential and proprietary inf ormation in ...

SMIC Q1 2025 Financial Presentation May 2025 Forward-Looking Statements This presentation may contain, in addition to historical information, forward-looking statements. These forward-looking statements are based on SMIC's current assumptions, expectations, beliefs, plans, objectives, and projections about future events or performance. SMIC uses words including but not limited to "believe", "anticipate", "intend", "estimate", "expect", "project", "target", "going forward", "continue", "ought to", "may", "se ...

2022 Interim Results Briefing September 2022 2022 H1 Overview 2021 H1 2022 H1 2021 H1 2022 H1 RMB 1.4bn Revenue RMB 0.9bn (66%) Gross Profit (Margin %) RMB 1.9bn R&D Expenses2 RMB 2.6bn Adjusted Net Loss3 RMB 19.5bn Cash Resources4 Maintain Leading Market Position and Strong Commercial Resilience Implementation of AI Technology in 4 Segments Smart Life yoy: +98% 2021 H1 2022 H1 Smart Auto yoy: +71% Smart Business yoy: -12% 2021 H1 2022 H1 Smart City yoy: -45% #1 ranked by market share5 China Computer Vision ...

SenseTime Group Inc. 2022 Annual Results Presentation 2023.03 Strong Foundation for Technology Breakthrough: SenseCore + Large Models 2 RMB 3.8bn Revenue (yoy -19%） Smart Life + Smart Auto revenue yoy +108% RMB 2.5bn (67%) Gross profit (gross margin %） FY2021 Smart City 45% Smart Business 42% Smart Life 9% Smart Auto 4% FY2022 Smart City 29% Smart Business 38% Smart Life 25% Smart Auto 8% 2022 Highlights Revenue Breakdown by Business Segments Notes： 1. Data as of 31 December 2022 2. Data as of 28 March 2922 ...

SenseTime Group Inc. 2023 Interim Results Presentation TO CREATE AN AI-EMPOWERED FUTURE THROUGH INNOVATION 2023.08 Overview - 01 2 Foundation Models Lead Evolution of AI Industry in 1H 2023 Breakthroughs in SenseNova Foundation Models Generative AI Product Suite Triple-digit % growth in generative AI-related revenue RMB 1.4 billion 1H 2023 Group Revenue (yoy: +1.3%) 10.4% FY 2022 1H 2023 20.3% Generative AI-related revenue RMB 2.4 billion ( 7% ） 1H 2023 GAAP net loss2 (yoy reduced) Note: 1. Data as of 30 Ju ...

SenseTime Group Inc. 2023 Annual Results Presentation TO CREATE AN AI-EMPOWERED FUTURE THROUGH INNOVATION 2024.03 —— Explosive Growth in Generative AI Revenue in 2023 10% 2022 2023 35% Revenue Operating Computing Power 12,000P Model-as-a-Service (MaaS) Revenue Growth of Group Revenue Operating Expenses 10.6% EBITDA (loss)2 (yoy reduced) RMB 5.5bn ( 2.2%) Group Revenue (yoy -10.6%） RMB 3.4bn Receivables collection (yoy +48.5%） RMB 3.8bn Total Employee (yoy reduced) 4,500+ ( 11.1%) Note: 1. Data as of 31 Dece ...

SenseTime Group Inc. 2024 Interim Results Presentation TO CREATE A BETTER AI-EMPOWERED FUTURE THROUGH INNOVATION 2024.08.27 —— Disclaimer The information in this presentation has been prepared by representatives of SenseTime Group Inc. (the "Company", and together with its subsidiaries, the "Group") for use in presentations by the Group for information purposes. No part of this presentation should form the basis of, or be relied on in connection with, any contract or commitment or investment decision whatso ...